ST14 and cancer: Five out of the twenty-five shared EMT-related genes (namely CTSL2, KLC3, SLPI, ST14 and STEAP1) were selected for the qPCR validation in that they are expressed at different levels in the erlotinib-sensitive and -resistant cells lines in the microarray data and were previously associated to cancer development (Figure 8c).